Acute renal failure

Lancet

Volumn 365, Issue 9457, 2005, Pages 417-430

  Lameire, Norbert ^a   Van Biesen, Wim ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ALLOPURINOL; AMINO ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTACID AGENT; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CELL ADHESION MOLECULE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FUROSEMIDE; MAGNESIUM DERIVATIVE; MANNITOL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN DERIVATIVE; SODIUM CHLORIDE; SOMATOMEDIN; SULFONAMIDE; THEOPHYLLINE; VASODILATOR AGENT;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; AUTOREGULATION; BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DNA POLYMORPHISM; HEMODIALYSIS; HEMODYNAMICS; HUMAN; HYPERKALEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; LEUKEMIA; LYMPHOMA; MEDICAL INFORMATION; MEDICAL RESEARCH; METABOLIC DISORDER; NEPHROTOXICITY; NONHUMAN; OBSTRUCTIVE UROPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT;

EID: 13144267730     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)70238-5     Document Type: Conference Paper

References (184)

1. Singri N, Ahja SN, Levin ML. Acute renal failure. JAMA. 289:2003;747-751
2. Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care. 8:2002;509-514
3. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol. 14:2003;2178-2187
4. Bellomo R, Ronco C, Kellum JA, Mehta R, Palevsky P, and the ADQI workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Coference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.
5. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 39:2002;930-936
6. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ. 306:1993;481-483
7. Khan IH, Catto GR, Edward N, MacLeod AM. Acute renal failure: factors influencing nephrology referral and outcome. QJM. 90:1997;781-785
8. Stevens PE, Tamimi NA, Al Hasani MK, et al. Non-specialist management of acute renal failure. QJM. 94:2001;533-540
9. Metcalfe W, Simpson M, Khan IH, et al. Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM. 95:2002;579-583
10. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal failure in intensive care units: causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study. Crit Care Med. 24:1996;192-198
11. de Mendonca A, Vincent JL, Suter PM, et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 26:2000;915-921
12. Liano F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int Suppl. 66:1998;S16-S24
13. Metnitz PGH, Krenn CG, Steltzer H, et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med. 30:2002;2051-2058
14. Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 351:2004;159-169
15. Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 66:2004;1613-1621
16. Blantz RC. Pathophysiology of pre-renal azotemia. Kidney Int. 53:1998;512-523
17. Badr KF, Ichikawa I. Prerenal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med. 319:1988;623-629
18. Baylis C, Brenner BM. Modulation by prostaglandin synthesis inhibitors of the action of exogenous angiotensin II on glomerular ultrafiltration in the rat. Circ Res. 43:1978;889-898
19. Dzau VJ, Packer M, Lilly LS, Swartz SL, Hollenberg NK, Williams GH. Prostaglandins in severe congestive heart failure: relation to activation of the renin-angiotensin system and hyponatremia. N Engl J Med. 310:1984;347-352
20. De Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II: glomerular and tubular interaction in the rat. J Clin Invest. 89:1992;1248-1256
21. Brater DC. Anti-inflammatory agents and renal function. Semin Arthritis Rheum. 32:(suppl 1):2002;33-42
22. Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med. 253:2003;643-652
23. Schepkens H, Vanholder R, Billiouw JM, Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med. 110:2001;438-441
24. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 351:2004;543-551
25. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 352:1998;13-16
26. Franklin SS, Smith RD. A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension. Nephron. 44:(suppl 1):1986;73-82
27. Bhandari S, Johnston P, Fowler RC, Joyce A, Turney JH. Non-dilated bilateral ureteric obstruction. Nephrol Dial Transplant. 10:1995;2337-2339
28. Chapman ME, Reid JH. Use of percutaneous nephrostomy in malignant ureteric obstruction. Br J Radiol. 64:1991;318-320
29. Yarger WE. Obstructive urinary tract disease in the elderly. Martinez-Maldonado M. Hypertension and renal disease in the elderly. 1992;272-308 Blackwell Scientific Publications, Boston
30. Klahr S. Obstructive uropathy. Seldin DW, Giebisch G. The kidney: physiology and pathophysiology. 3th edn:2000;2473-2512 Lippincott Williams & Wilkins, Philadelphia
31. Barsoum RS. Tropical acute renal failure. Contrib Nephrol. 144:2004;44-52
32. Sever MS, Erek E, Vanholder R, et al. Lessons learned from the catastrophic Marmara earthquake: factors influencing the final outcome of renal victims. Clin Nephrol. 61:2004;413-421
33. Lameire N, Mehta R, Vanholder R, Sever M. The organization and interventions of the ISN Renal Disaster Relief Task Force. Adv Ren Replace Ther. 10:2003;93-99
34. Cole L, Bellomo R, Silvester W, Reeves JH. A prospective, multicenter study of the epidemiology, management, and outcome of severe acute renal failure in "closed" ICU system. Am J Respir Crit Care Med. 162:2000;191-196
35. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol. 14:2003;1022-1030
36. Breen D, Bihari D. Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness. Kidney Int Suppl. 66:1998;S25-S33
37. Carmichael P, Carmichael AR. Acute renal failure in the surgical setting. Aust NZ J Surg. 73:2003;144-153
38. Deman A, Hoste E, Van Biesen W, Vanholder R, Lameire N. Insuffisance rénale aigue postopératoire: épidémiologie, causes, pronostic et traitement. Lesavre P, Drueke T, Legendre C, Niaudet P. Actualités néphrologiques Jean Hamburger. 2004;227-254 Flammarion, Paris
39. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 275:1996;1489-1494
40. Gruber SJ, Shapiro CJ. Nephropathy induced by contrast medium. N Engl J Med. 348:2003;2257-2259
41. Dillon JJ. Nephrotoxicity from antibacterial, antifungal, and antiviral drugs. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;349-364 WB Saunders, Philadelphia
42. Agraharkar M, Guba SC, Safirstein RL. Acute renal failure associated with cancer chemotherapy. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;365-375 WB Saunders, Philadelphia
43. Boccalandro F, Anderson HV. Contrast-induced nephropathy: back to basics. J Invasive Cardiol. 15:2003;317-318
44. Evenepoel P. Acute toxic renal failure. Best Pract Res Clin Anaesthesiol. 18:2004;37-52
45. Bach PH. Acute renal failure associated with occupational and environmental settings. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;414-424 WB Saunders, Philadelphia
46. Turney JH. Acute renal failure associated with recreational drug use. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;397-405 WB Saunders, Philadelphia
47. Kaushal GP, Portilla D, Megyesi E, Price PM, Safirstein RL. Cellular mechanisms of nephrotoxicity. De Broe ME, Porter GA, Bennet WM, Verpooten GA. Clinical nephrotoxins. 2nd edn:2003;65-76 Kluwer Academic Publishers, Dordrecht
48. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 348:2003;138-150
49. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 345:2001;588-595
50. Kon V, Badr KF. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int. 40:1991;1-12
51. Filep JG. Role for endogenous endothelin in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Br J Pharmacol. 129:2000;975-983
52. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med. 30:(suppl):2002;S302-S312
53. Schwartz D, Mendonca M, Schwartz I, et al. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest. 100:1997;439-448
54. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol. 14:2003;2199-2210
55. Lameire NH, Vanholder R. Pathophysiology of ischaemic acute renal failure. Best Pract Res Clin Anaesthesiol. 18:2004;21-36
56. Molitoris BA. Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol. 14:2003;265-267
57. Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 66:2004;496-499
58. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 114:2004;5-14
59. Lieberthal W, Nigam SK. Acute renal failure II: experimental models of acute renal failure - imperfect but indispensable. Am J Physiol Renal Physiol. 278:2000;F1-12
60. Heyman SN, Lieberthal W, Rogiers P, Bonventre JV. Animal models of acute tubular necrosis. Curr Opin Crit Care. 8:2002;526-534
61. Rosen S, Heyman SN. Difficulties in understanding human "acute tubular necrosis": limited data and flawed animal models. Kidney Int. 60:2001;1220-1224
62. Bohle A, Christensen J, Kokot F, et al. Acute renal failure in man: new aspects concerning pathogenesis: a morphometric study. Am J Nephrol. 10:1990;374-388
63. Racusen LC. The morphologic basis of acute renal failure. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;1-12 WB Saunders, Philadelphia
64. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. 334:1996;1448-1460
65. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med. 332:1995;647-655
66. Hollenberg NK, Epstein M, Rosen SM, Basch RI, Oken DE, Merrill JP. Acute oliguric renal failure in man: evidence for preferential renal cortical ischemia. Medicine (Baltimore). 47:1968;455-474
67. Hollenberg NK, Adams DF, Oken DE, Abrams HL, Merrill JP. Acute renal failure due to nephrotoxins: renal hemodynamic and angiographic studies in man. N Engl J Med. 282:1970;1329-1334
68. Reubi FC. The pathogenesis of anuria following shock. Kidney Int. 5:1974;106-110
69. Conger JD. Vascular alterations in acute renal failure: roles in inititation and maintenance. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;13-29 WB Saunders, Philadelphia
70. Brodsky SV, Yamamoto T, Tada T, et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol. 282:2002;F1140-F1149
71. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int. 62:2002;1539-1549
72. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 66:2004;480-485
73. Ysebaert DK, De Greef KE, De Beuf A, cells as mediators in renal ischemia/reperfusion injury. T, et al. Kidney Int. 66:2004;491-496
74. Rabb H. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int. 61:2002;1935-1946
75. Zuk A, Bonventre JV, Matlin KS. Expression of fibronectin splice variants in the postischemic rat kidney. Am J Physiol Renal Physiol. 280:2001;F1037-F1053
76. Atkinson SJ, Molitoris BA. Cytoskeletal alterations as a basis of cellular injury in acute reanl failure. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;119 WB Saunders, Philadelphia
77. Molitoris BA. Actin cytoskeleton in ischemic acute renal failure. Kidney Int. 66:2004;871-883
78. Alejandro VS, Nelson WJ, Huie P, et al. Postischemic injury, delayed function and Na+/K(+)-ATPase distribution in the transplanted kidney. Kidney Int. 48:1995;1308-1315
79. Goligorsky MS, Noiri E. Duality of nitric oxide in acute renal injury. Semin Nephrol. 19:1999;263-271
80. Noiri E, Peresleni T, Miller F, Goligorsky MS. In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia. J Clin Invest. 97:1996;2377-2383
81. Noiri E, Nakao A, Uchida K, et al. Oxidative and nitrosative stress in acute renal ischemia. Am J Physiol Renal Physiol. 281:2001;F948-F957
82. Gailit J, Colflesh D, Rabiner I, Simone J, Goligorsky M. Redistribution and and dysfunction of integrins in cultured renal epithelial cells exposed to oxidative stress. Am J Physiol. 264:1993;F149-F157
83. Romanov V, Noiri E, Czerwinski G, Finsinger D, Kessler H, Goligorsky MS. Two novel probes reveal tubular and vascular Arg-Gly-Asp (RGD) binding sites in the ischemic rat kidney. Kidney Int. 52:1997;93-102
84. Wangsiripaisan A, Gengaro PE, Edelstein CL, Schrier RW. Role of polymeric Tamm-Horsfall protein in cast formation: oligosaccharide and tubular fluid ions. Kidney Int. 59:2001;932-940
85. Dagher PC. Apoptosis in ischemic renal injury: roles of GTP depletion and p53. Kidney Int. 66:2004;506-509
86. Kaushal GP, Basnakian AG, Shah SV. Apoptotic pathways in ischemic acute renal failure. Kidney Int. 66:2004;500-506
87. Bonegio R, Lieberthal W. Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens. 11:2002;301-308
88. Oberbauer R, Rohrmoser M, Regeler H, et al. Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol. 10:1999;2006-2013
89. Price PM, Megyesi J, Saf Irstein RL. Cell cycle regulation: repair and regeneration in acute renal failure. Kidney Int. 66:2004;509-514
90. Al Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int. 61:2002;387-395
91. Hammerman MR, Miller SB. Therapeutic use of growth factors in renal failure. J Am Soc Nephrol. 5:1994;1-11
92. Rookmaaker MB, Verhaar MC, Van Zonneveld AJ, Rabelink TJ. Progenitor cells in the kidney: biology and therapeutic perspectives. Kidney Int. 66:2004;518-522
93. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 105:2001;369-377
94. Verfaillie CM, Pera MF, Lansdorp PM. Stem cells: hype and reality. Hematology (American Society of Hematology Education Program) 2002: 369-91.
95. Ito T. Stem cells of the adult kidney: where are you from? Nephrol Dial Transplant. 18:2003;641-644
96. Poulsom R, Forbes SJ, Hodivala-Dilke K, et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol. 195:2001;229-235
97. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 112:2003;42-49
98. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol. 15:2004;1794-1804
99. Togel F, Isaac J, Westenfelder C. Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J Am Soc Nephrol. 15:2004;1261-1267
100. Anderson RJ, Barry DW. Clinical and laboratory diagnosis of acute renal failure. Best Pract Res Clin Anaesthesiol. 18:2004;1-20
101. Kieran N, Brady HR. Clinical evaluation, management, and outcome of acute renal failure. Johnson RJ, Feehally J. Comprehensive clinical nephrology. 2nd edn:2003;183-206 Mosby, Edinburgh
102. Wuyts B, Bernard D, Van Den Noortgate N, et al. Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin Chem. 49:2003;1011-1014
103. Delanghe JR. Standardization of creatinine determination and its consequences for the clinician. Acta Clin Belg. 57:2002;172-175
104. Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 39:2002;920-929
105. Schuck O, Teplan V, Jabor A, Stollova M, Skibova J. Glomerular filtration rate estimation in patients with advanced chronic renal insufficiency based on serum cystatin C levels. Nephron Clin Pract. 93:2003;c146-c151
106. Schuck O, Teplan V, Sibova J, Stollova M. Predicting the glomerular filtration rate from serum creatinine, serum cystatin C and the Cockcroft and Gault formula with regard to drug dosage adjustment. Int J Clin Pharmacol Ther. 42:2004;93-97
107. Delanaye P, Lambermont B, Chapelle JP, Gielen J, Gerard P, Rorive G. Plasmatic cystatin C for the estimation of glomerular filtration rate in intensive care units. Intensive Care Med. 30:2004;980-983
108. Herget-Rosenthal S, Marggraf G, Husing J, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 66:2004;1115-1122
109. Rickli H, Benou K, Ammann P, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 61:2004;98-102
110. Miller PD, Krebs RA, Neal BJ, McIntyre DO. Polyuric prerenal failure. Arch Intern Med. 140:1980;907-909
111. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int. 62:2002;2223-2229
112. Finn WF, Porter GA. Urinary biomarkers and nephrotoxicity. De Broe ME, Porter GA, Bennet WM, Verpooten GA. Clinical nephrotoxins renal injury from drugs and chemicals. 2nd edn:2003;622-655 Kluwer Academic Publishers, Dordrecht
113. Hewitt SM, Dear J, Star RA. Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol. 15:2004;1677-1689
114. Parikh CR, Jani A, Melnikov VY, Faubel S, Edelstein CL. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 43:2004;405-414
115. Westhuyzen J, Endre ZH, Reece G, Reith DM, Saltissi D, Morgan TJ. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant. 18:2003;543-551
116. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 62:2002;237-244
117. Hampel DJ, Sansome C, Sha M, Brodsky S, Lawson WE, Goligorsky MS. Toward proteomics in uroscopy: urinary protein profiles after radiocontrast medium administration. J Am Soc Nephrol. 12:2001;1026-1035
118. Conger JD. Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis. 26:1995;565-576
119. Dishart MK, Kellum JA. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs. 59:2000;79-91
120. Kellum JA. What can be done about acute renal failure? Minerva Anestesiol. 70:2004;181-188
121. Lameire NH, De Vriese AS, Vanholder R. Prevention and nondialytic treatment of acute renal failure. Curr Opin Crit Care. 9:2003;481-490
122. Ribeiro RC, Pui CH. Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies. Clin Lymphoma. 3:2003;225-232
123. De Vriese AS, Bourgeois M. Pharmacologic treatment of acute renal failure in sepsis. Curr Opin Crit Care. 9:2003;474-480
124. De Vriese AS. Prevention and treatment of acute renal failure in sepsis. J Am Soc Nephrol. 14:2003;792-805
125. Choi PT, Yip G, Quinonez LG, Cook DJ. Crystalloids vs colloids in fluid resuscitation: a systematic review. Crit Care Med. 27:1999;200-210
126. Ragaller MJ, Theilen H, Koch T. Volume replacement in critically ill patients with acute renal failure. J Am Soc Nephrol. 12:(suppl 17):2001;S33-S39
127. Waikar SS, Chertow GM. Crystalloids versus colloids for resuscitation in shock. Curr Opin Nephrol Hypertens. 9:2000;501-504
128. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 350:2004;2247-2256
129. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 162:2002;329-336
130. Kellum JA. Use of diuretics in the acute care setting. Kidney Int Suppl. 66:1998;S67-S70
131. Schetz M. Should we use diuretics in acute renal failure? Best Pract Res Clin Anaesthesiol. 18:2004;75-89
132. Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 12:1997;2592-2596
133. Mehta RL, Pascual MT, Soroko S, Chertow GM. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 288:2002;2547-2553
134. Mehta RL, Chertow GM. Diuretics in critically ill patients with acute renal failure. JAMA. 289:2003;1379-1381
135. Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med. 32:2004;1669-1677
136. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo- controlled randomised trial. Lancet. 356:2000;2139-2143
137. Denton MD, Chertow GM, Brady HR. Renal-dose" dopamine for the treatment of acute renal failure: scientific rationale, experimental studies and clinical trials. Kidney Int. 50:1996;4-14
138. Kellum JA, Decker M. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 29:2001;1526-1531
139. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml J, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 11:2000;97-104
140. Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 43:2004;1-9
141. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet. 362:2003;598-603
142. Isenbarger DW, Kent SM, O'Malley PG. Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy. Am J Cardiol. 92:2003;1454-1458
143. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 15:2004;407-410
144. Ladefoged SD, Andersen CB. Calcium channel blockers in kidney transplantation. Clin Transplant. 8:1994;128-133
145. Lumlertgul D, Wongmekiat O, Sirivanichai C, et al. Intrarenal infusion of gallopamil in acute renal failure: a preliminary report. Drugs. 42:(suppl 1):1991;44-50
146. Piper SN, Kumle B, Maleck WH, et al. Diltiazem may preserve renal tubular integrity after cardiac surgery. Can J Anaesth. 50:2003;285-292
147. Sharples EJ, Patel N, Brown P, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 15:2004;2115-2124
148. Hirschberg R, Kopple J, Lipsett P, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int. 55:1999;2423-2432
149. Hladunewich MA, Corrigan G, Derby GC, et al. A randomized, placebo-controlled trial of IGF-1 for delayed graft function: a human model to study postischemic ARF. Kidney Int. 64:2003;593-602
150. Bellomo R, Naka T, Baldwin I. Intravenous fluids and acid-base balance. Contrib Nephrol. 144:2004;105-118
151. Schetz M, Van Den BG. Glucose control in the critically ill. Contrib Nephrol. 144:2004;119-131
152. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 345:2001;1359-1367
153. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 31:2003;359-366
154. D'Intini V, Ronco C, Bonello M, Bellomo R. Renal replacement therapy in acute renal failure. Best Pract Res Clin Anaesthesiol. 18:2004;145-157
155. Lameire N, Van Biesen W, Vanholder R. Dialysing the patient with acute renal failure in the ICU: the emperor's clothes? Nephrol Dial Transplant. 14:1999;2570-2573
156. Van Biesen W, Vanholder R, Lameire N. Dialysis strategies in critically ill acute renal failure patients. Curr Opin Crit Care. 9:2003;491-495
157. John S, Griesbach D, Baumgartel M, Weihprecht H, Schmieder RE, Geiger H. Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant. 16:2001;320-327
158. Manns B, Doig CJ, Lee H, et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med. 31:2003;449-455
159. Mehta RL, McDonald B, Gabbai FB, et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int. 60:2001;1154-1163
160. Sandy D, Moreno L, Lee J, Paganini E. A randomized stratified dose aquivalent comparison of continuous veno-venous hemodialysis vs intermittent hemodialysis support in ICU acute renal failure patients. J Am Soc Nephrol 1998; 9: 225A (abstr).
161. Uehlinger DE, Jacob S, Eichelberger M. A randomized, controlled single center study for the comparison of continuous renal replacement therapy with intermittent hemodialysis in critically ill patients with acute renal failure. J Am Soc Nephrol 2001; 12: 278A (abstr).
162. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis. 40:2002;875-885
163. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 356:2000;26-30
164. Lameire N, Van Biesen W, Vanholder R, Hoste E. Intermittent hemodialysis for acute renal failure patients: an update. Contrib Nephrol. 144:2004;255-263
165. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 346:2002;305-310
166. Ikizler TA, Sezer MT, Flakoll PJ, et al. Urea space and total body water measurements by stable isotopes in patients with acute renal failure. Kidney Int. 65:2004;725-732
167. Jaber BL, Lau J, Schmid CH, Karsou SA, Levey AS, Pereira BJ. Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure: a meta-analysis. Clin Nephrol. 57:2002;274-282
168. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int. 62:2002;1819-1823
169. Teehan GS, Liangos O, Jaber BL. Update on dialytic management of acute renal failure. J Intensive Care Med. 18:2003;130-138
170. Teehan GS, Liangos O, Lau J, Levey AS, Pereira BJ, Jaber BL. Dialysis membrane and modality in acute renal failure: understanding discordant meta-analyses. Semin Dial. 16:2003;356-360
171. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int. 60:2001;777-785
172. Marshall MR, Ma T, Galler D, Rankin AP, Williams AB. Sustained low-efficiency daily diafiltration (SLEDD-f) for critically ill patients requiring renal replacement therapy: towards an adequate therapy. Nephrol Dial Transplant. 19:2004;877-884
173. Kumar VA, Yeun JY, Depner TA, Don BR. Extended daily dialysis vs continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report. Int J Artif Organs. 27:2004;371-379
174. Karsou SA, Jaber BL, Pereira BJ. Impact of intermittent hemodialysis variables on clinical outcomes in acute renal failure. Am J Kidney Dis. 35:2000;980-991
175. d'Avila DO, Cendoroglo NM, dos Santos OF, Schor N, de Figueiredo CE. Acute renal failure needing dialysis in the intensive care unit and prognostic scores. Ren Fail. 26:2004;59-68
176. Guerin C, Girard R, Selli JM, Ayzac L. Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med. 28:2002;1411-1418
177. McCarthy JT. Prognosis of patients with acute renal failure in the intensive-care unit: a tale of two eras. Mayo Clin Proc. 71:1996;117-126
178. Jaber BL, Rao M, Guo D, et al. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine. 25:2004;212-219
179. Jaber BL, Liangos O, Pereira BJ, Balakrishnan VS. Polymorphism of immunomodulatory cytokine genes: implications in acute renal failure. Blood Purif. 22:2004;101-111
180. Finn WF. Recovery from acute renal failure. Molitoris BA, Finn WF. Acute renal failure: a companion to Brenner and Rector's the kidney. 1st edn:2001;425-450 WB Saunders, Philadelphia
181. Alon US. Neonatal acute renal failure: the need for long-term follow-up. Clin Pediatr (Phila). 37:1998;387-389
182. Polito C, Papale MR, La Manna A. Long-term prognosis of acute renal failure in the full-term neonate. Clin Pediatr (Phila). 37:1998;381-385
183. Shaw NJ, Brocklebank JT, Dickinson DF, Wilson N, Walker DR. Long-term outcome for children with acute renal failure following cardiac surgery. Int J Cardiol. 31:1991;161-165
184. Bhandari S, Turney JH. Survivors of acute renal failure who do not recover renal function. QJM. 489:1996;415-421